Global Med Technologies(R), Inc. Continues Its Strong Double-Digit Revenue Growth With a 95.5% Increase and Net Income of $313 T
2005年8月3日 - 10:30PM
PRニュース・ワイアー (英語)
DENVER, Aug. 3 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global
Med" or the "Company") reported net income of $313 thousand and
revenues of $2.854 million for the three months ended June 30,
2005, an increase of 95.5% from the $1.460 million in revenues
recorded during the three months ended June 30, 2004. During the
three months ended June 30, 2004, the Company's net loss was $372
thousand. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) The
Company's comparable quarter-to-quarter revenue growth rate has
been as follows ($000s): Revenues for the Revenues for the
Percentage Three Months Ended Three Months Ended Change 2003 2004
September 30, $1,279 $1,794 40.3% December 31, $1,417 $2,277 60.7%
2004 2005 March 31, $1,353 $2,575 90.3% June 30, $1,460 $2,854
95.5% The Company generated sales in the form of customer contracts
for software license and implementation fees of approximately $1.6
million* during the quarter ended June 30, 2005. As a result of
this robust second quarter, the Company's customer billings were
approximately $3 million and cash collections of receivables was
approximately $2.6 million. Strong cash collections resulted in the
Company's operations providing $225 thousand in cash flows. The
Company's cash balance increased to $1.918 million as of June 30,
2005 from $1.633 million as of December 31, 2004. Global Med's
President and COO, Thomas F. Marcinek, commenting on the results
for the second quarter stated, "The Company had another outstanding
quarter. Our revenues continued to increase at a double-digit pace,
and we posted net income of $313 thousand, our third consecutive
quarter of net income. In addition, our backlog of unrecognized
software license and implementation fees continues to remain strong
at over $5.2 million**, a $400 thousand increase from March 31,
2005." Michael I. Ruxin, M.D., Chairman and CEO of Global Med
Technologies, Inc., stated, "The second quarter results exceeded
the Company's expectations of strong double-digit growth. Our
revenue growth has continued to accelerate during the last four
quarters from 40.3% to 60.7% to 90.3% to 95.5%." Dr. Ruxin
continued, "The Company's qualified pipeline of prospective
business also continues to grow. Our third quarter sales are
already encouraging. We continue to bring new customers on board,
and we anticipate continued strong double-digit annual growth
through the remainder of 2005." The following table provides
certain details related to the Company's operations for the three
and six months ended June 30, 2005 and 2004: Global Med
Technologies, Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) Selected
Quarterly Results Three Months Ended In (000s) except per share
information (Unaudited) June 30, 2005 June 30, 2004 Revenues $2,854
$1,460 Cost of sales $834 $621 Operating expenses $1,700 $1,184
Income (loss) from operations $320 $(345) Net income (loss) $313
$(372) Preferred dividends, related party $(183) $(189) Net income
(loss) attributable to common shareholders $130 $(561) Net income
(loss) per common share Basic $0.00 $(0.02) Diluted $0.00 $(0.02)
Common shares outstanding Basic 27,705 25,626 Diluted 42,225 25,626
Cash flows provided by (used in) operations $225 $(618) Global Med
Technologies, Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) Selected
Quarterly Results Six Months Ended In (000s) except per share
information (Unaudited) June 30, 2005 June 30, 2004 Revenues $5,429
$2,813 Cost of sales $1,511 $1,184 Operating expenses $3,474 $2,284
Income (loss) from operations $444 $(655) Net income (loss) $430
$(820) Preferred dividends, related party $(330) $(189) Net income
(loss) attributable to common shareholders $100 $(448) Net income
(loss) per common share Basic $0.00 $(0.02) Diluted $0.00 $(0.02)
Common shares outstanding Basic 27,665 25,089 Diluted 42,372 25,089
Cash flows provided by (used in) operations $364 $(612) * Of the
$1.6 million sales for Q-2, 2005, approximately $100 thousand
relates to fees, for which there is a variable component. ** Of the
approximate $5.2 million backlog, approximately $300 thousand
relates to fees, for which there is a variable component. About
Global Med Technologies(R), Inc. Global Med Technologies(R), Inc.
is an international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. For more information about Global Med's products
and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. Statements in this press release that are
not strictly historical are "forward-looking" statements within the
meaning of the Safe Harbor provisions of the federal securities
laws. Forward-looking statements involve risks and uncertainties,
including, but not limited to, continued acceptance of the
Company's products and services in the marketplace, regulatory and
competitive factors, new products and technological changes, the
Company's dependence upon third-party suppliers, and other risks
detailed from time to time in the Company's Form 10-K and other
regularly filed reports. The results of operations for the quarter
or year ended June 30, 2005 are not necessarily indicative of the
results that may be expected for any other future period. Photo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO AP
Archive: http://photoarchive.ap.org PRN Photo Desk,
photodesk@prnewswire.com DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: Michael I. Ruxin, M.D., Chairman and CEO of Global
Med Technologies(R), Inc., +1-303-238-2000; or Investors, John
Nesbett or Jordan Silverstein of The Investor Relations Group,
+1-212-825-3210, for Global Med Technologies(R), Inc. Web site:
http://www.globalmedtech.com/
Copyright